Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Synapse Medical Resourcing Ltd

Synapse Medical Resourcing specialises in finding companies the most talented medical professionals for their organisation, and provides medically qualified doctors with the latest information about opportunities within the pharmaceutical industry. Synapse was founded in 2004 by a practising Pharmaceutical Physician to find the most suitable positions for doctors currently working in, or considering moving into, the pharmaceutical industry. Utilising our Directors contacts with medical organisations and networks, we have built one of the largest databases of doctors currently working in, or looking to move into, the pharmaceutical industry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Synapse Medical Resourcing Ltd
Exclusively Recruiting Pharmaceutical Physicians, 100 Eton Place, Eton College Road, London, NW3 2DT, United Kingdom
+44 (0)20 7962 0555
Contact Synapse Medical Resourcing Ltd
Website

 Latest Content from PMHub 

Havas Lynx celebrates 40 years of impact

Press Releases | May 6, 2026 | Havas Lynx

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international healthcare communications agency with offices...

Cuttsy+Cuttsy welcomes three new experts to the team

Press Releases | May 6, 2026 | Cuttsy + Cuttsy

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands

Press Releases | May 6, 2026 | Uniphar

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Press Releases | May 5, 2026 | Inizio

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

Personalization, automation and actionable intelligence: How to achieve purposeful innovation in healthcare communications

White Papers and Resources | May 5, 2026 | Amiculum

By Aaron Fletcher

The silent drop-off: How disengagement shows up in everyday behaviour

Press Releases | May 5, 2026 | Mednet

In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, in what is delayed, avoided...

Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026

Press Releases | May 5, 2026 | Medscape Education

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...

The Power of Partnership in Respiratory Care

Press Releases | May 5, 2026 | Medscape Education

In the fast-paced world of modern medicine, success is often measured by the volume of tests and the precision of data. However, as Dr. Doreen Addrizzo-Harris and Dr. Martina Flammer...

Why clinical innovation doesn’t translate into real-life outcomes

Press Releases | April 30, 2026 | Mednet

We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their lives.

Strategies to enhance the provider and patient EAP experience

White Papers and Resources | April 30, 2026 | Uniphar

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.